LU84974A1 - Nouveaux derives de la benzamide,leur preparation et les compositions pharmaceutiques qui les contiennent - Google Patents

Nouveaux derives de la benzamide,leur preparation et les compositions pharmaceutiques qui les contiennent Download PDF

Info

Publication number
LU84974A1
LU84974A1 LU84974A LU84974A LU84974A1 LU 84974 A1 LU84974 A1 LU 84974A1 LU 84974 A LU84974 A LU 84974A LU 84974 A LU84974 A LU 84974A LU 84974 A1 LU84974 A1 LU 84974A1
Authority
LU
Luxembourg
Prior art keywords
benzamide
imidazolyl
radical
propyl
benzenesulfonamido
Prior art date
Application number
LU84974A
Other languages
English (en)
French (fr)
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of LU84974A1 publication Critical patent/LU84974A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU84974A 1982-08-24 1983-08-23 Nouveaux derives de la benzamide,leur preparation et les compositions pharmaceutiques qui les contiennent LU84974A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8224296 1982-08-24
GB8224296 1982-08-24

Publications (1)

Publication Number Publication Date
LU84974A1 true LU84974A1 (fr) 1984-03-23

Family

ID=10532494

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84974A LU84974A1 (fr) 1982-08-24 1983-08-23 Nouveaux derives de la benzamide,leur preparation et les compositions pharmaceutiques qui les contiennent

Country Status (23)

Country Link
US (1) US4507315A (xx)
JP (1) JPS5955873A (xx)
KR (1) KR840005717A (xx)
AT (1) ATA301083A (xx)
AU (1) AU1818083A (xx)
BE (1) BE897580A (xx)
CA (1) CA1195993A (xx)
CS (1) CS240973B2 (xx)
DE (1) DE3330403A1 (xx)
DK (1) DK386783A (xx)
ES (2) ES525099A0 (xx)
FI (1) FI832989A (xx)
FR (1) FR2532310B1 (xx)
GB (1) GB2126225B (xx)
GR (1) GR78673B (xx)
IL (1) IL69544A0 (xx)
IT (1) IT1169775B (xx)
LU (1) LU84974A1 (xx)
NL (1) NL8302947A (xx)
NO (1) NO833024L (xx)
PT (1) PT77219B (xx)
SE (1) SE8304545L (xx)
ZA (1) ZA836191B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625144B2 (ja) * 1986-02-24 1994-04-06 四国化成工業株式会社 新規イミダゾール化合物及び該化合物の合成方法
US4916145A (en) * 1987-07-10 1990-04-10 Hoffmann-La Roche Inc. Substituted n-[(pyridyl)alkyl]aryl-carboxamide
US4886629A (en) * 1988-06-06 1989-12-12 Allied-Signal Inc. Process for the preparation of fluorinated benzene sulfonyl fluorides
CA2057324A1 (en) * 1990-12-18 1992-06-19 Lora Louise Fitch Benzamide and sulfonamide hypoglycemic agents
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
EP1196385A1 (en) * 1999-07-06 2002-04-17 Vertex Pharmaceuticals Incorporated Beta-amino acid derivatives for the treatment of neurological diseases
DE10121003A1 (de) * 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
BRPI0516027A (pt) * 2004-09-24 2008-08-19 Janssen Pharmaceutica Nv compostos de sulfonamida

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3349124A (en) * 1957-05-20 1967-10-24 Pfizer & Co C Oral antidiabetic agent
BE756062A (fr) * 1969-09-11 1971-03-11 Boehringer Sohn Ingelheim Derives de 1,1,1-trichlorethane leurs procedes de fabrication et leur utilisation en tant que substances biocides
DE2500157C2 (de) * 1975-01-03 1983-09-15 Hoechst Ag, 6230 Frankfurt N-Acyl-4-(2-aminoäthyl)-benzoesäuren, deren Salze und Ester, Verfahren zu deren Herstellung und deren Verwendung
DE2517229A1 (de) * 1975-04-18 1976-10-28 Boehringer Mannheim Gmbh Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung
DK148576A (da) * 1975-04-18 1976-10-19 Boehringer Mannheim Gmbh Fenylalkankarbonsyrederivater og fremgangsmade til deres fremstilling
US4317915A (en) * 1976-08-23 1982-03-02 Hoffmann-La Roche Inc. Novel thiophene derivatives
NZ186175A (en) * 1977-01-27 1980-03-05 Shionogi & Co Meta-sulphonamidobenzamide derivatives
US4245120A (en) * 1977-09-27 1981-01-13 American Cyanamid Company 4-(Monoalkylamino)benzene polycarboxylic acids
LU79008A1 (de) * 1978-02-03 1979-09-06 Byk Gulden Lomberg Chem Fab W-(n-alkyl-n-benzoyl-amino)-phenylalkansaeuren,ihre verwendung und herstellung sowie sie enthaltende arzneimittel

Also Published As

Publication number Publication date
GR78673B (xx) 1984-09-27
DK386783D0 (da) 1983-08-23
IL69544A0 (en) 1983-11-30
DK386783A (da) 1984-02-25
CS612483A2 (en) 1985-06-13
GB8322539D0 (en) 1983-09-21
DE3330403A1 (de) 1984-03-01
BE897580A (fr) 1984-02-23
ES8502691A1 (es) 1985-01-16
GB2126225B (en) 1985-10-09
JPS5955873A (ja) 1984-03-31
ATA301083A (de) 1985-11-15
ES525099A0 (es) 1985-01-16
SE8304545D0 (sv) 1983-08-22
IT1169775B (it) 1987-06-03
ES8505935A1 (es) 1985-06-16
NO833024L (no) 1984-02-24
NL8302947A (nl) 1984-03-16
ES528012A0 (es) 1985-06-16
FI832989A0 (fi) 1983-08-22
FR2532310A1 (fr) 1984-03-02
IT8322629A0 (it) 1983-08-24
SE8304545L (sv) 1984-02-25
CA1195993A (en) 1985-10-29
FR2532310B1 (fr) 1986-01-10
FI832989A (fi) 1984-02-25
ZA836191B (en) 1984-04-25
GB2126225A (en) 1984-03-21
PT77219B (fr) 1986-02-04
AU1818083A (en) 1984-03-01
PT77219A (fr) 1983-09-01
CS240973B2 (en) 1986-03-13
US4507315A (en) 1985-03-26
KR840005717A (ko) 1984-11-16

Similar Documents

Publication Publication Date Title
EP0202164B1 (fr) Dérivés de (benzoyl-4 pipéridino)-2 phenyl-1 alcanols, leur préparation et leur application en thérapeutique
EP0379441A1 (fr) Nouveaux dérivés du benzopyranne, leur preparation et les compositions pharmaceutiques qui les contiennent
EP0350403A1 (fr) Dérivés de (aza)naphtalènesultame, leurs procédés de préparation et les médicaments les contenant
FR2531707A1 (fr) Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
CH635080A5 (fr) Pyrazoles substitues en position 4, leur preparation et leur utilisation therapeutique.
CH627447A5 (en) Process for the preparation of 4-(hydroxyphenyl)alkanolamine derivatives
EP0068968B1 (fr) Nouveaux médicaments contenant à titre de substance active des composés du type arylbenzènesulfonamide et leurs procédés de préparation
LU84974A1 (fr) Nouveaux derives de la benzamide,leur preparation et les compositions pharmaceutiques qui les contiennent
EP1185526B1 (fr) Derives d' amonium quaternaire, leur procede de preparation et leur usage en pharmacie
EP0418933A1 (fr) Dérivés d'alcadiènes, leurs préparations, les médicaments les contenant et produits intermédiaires
FR2662442A1 (fr) Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.
FR2612517A1 (fr) Derives de benzoxazine, procedes de preparation de ces derives et compositions pharmaceutiques les contenant
EP0004494A1 (fr) Nouveaux dérivés de 1,3-dihydro 3-(1-(2-(2,3-dihydro 1,4-benzo-dioxin-2-yl)2-hydroxy éthyl)pipéridin-4-yl)2H-indol 2-one, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
EP0000452B1 (fr) Dérivés d'oxadiazole-1,2,4, leur préparation et leur application en thérapeutique.
FR2528846A1 (fr) Nouveau derive de la pyrazolo (1,5-a) pyridine, sa preparation et les compositions pharmaceutiques qui le contiennent
LU81554A1 (de) Alkylthiophenoxyalkylamines
LU85780A1 (fr) Nouveaux esters enoliques precurseurs de medicaments et composition pharmaceutique les contenant
WO1992018497A1 (fr) Nouvelles quinolones difluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant
EP0017523B1 (fr) Nouveaux dérivés du dithiépinno (1,4)(2,3-c)pyrrole, leur préparation et les médicaments qui les contiennent
EP0061379B1 (fr) Dérivés de pyridine, leur préparation et leur application en thérapeutique
CH620678A5 (en) Process for the preparation of a derivative of piperidine
LU83127A1 (fr) Derives benzylideniques,leur preparation et leur application en therapeutique
WO1983003607A1 (en) New cyanoguanidines, method for obtaining them and pharmaceutical compositions containing them
EP0120741B1 (fr) Nouveaux médicaments dérivés de la chloro-4 dithiole-1,2 one-3 et les compositions médicinales qui les contiennent
FR2464952A1 (fr) Nouveaux derives thienyliques, leur procede de preparation et leur application comme medicaments